September 02, 2025
Major insulin makers Eli Lilly, Novo Nordisk and Sanofi and the three largest pharmacy benefit managers have been hit with a fresh lawsuit accusing them of artificially inflating the cost of the diabetes medicine. Elsewhere, an Idaho federal judge tossed a group of neurosurgeons' antitrust claims against a healthcare system.